Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

A systematic review and meta-analysis from the Harvard T.H. Chan School of Public Health reported a large effect of ...

The patent, when formally approved, will reinforce protection for Silo’s lead asset, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The patent includes newly added ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for ...

Long-term Tecfidera use was found to significantly reduce relapse rates and slow disability progression for MS patients in a ...

The first patient in the UK with advanced bowel cancer to receive a liver transplant after the disease spread to it has said ...

A young woman is cancer-free after undergoing the UK’s first liver transplant for advanced bowel cancer. Bianca Perea, a ...

Discover why psychiatrists are moving beyond single-treatment approaches and how combining therapies could be the key to ...

Most MS treatments don't increase the risk for miscarriage or major birth defects when used during pregnancy, an analysis ...